Douglas Ward

Chief Executive Officer at LUMOS DIAGNOSTICS HOLDINGS LIMITED

Net worth: 18 905 $ as of 2024-03-30

Health Technology

Consumer Services

Profile

Douglas Ward is currently the Chief Executive Officer, Director, and Managing Director at Lumos Diagnostics Holdings Ltd.
He previously served as the Chief Executive Officer at Personal Genome Diagnostics, Inc. from 2016 to 2020.
Additionally, he held the position of Vice President of Strategy and Business Development at Hologic, Inc. Mr. Ward completed his undergraduate degree at Ohio Wesleyan University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
LUMOS DIAGNOSTICS HOLDINGS LTD. 0.10%	2023-10-17	475,000 ( 0.10% )	18 905 $	2024-03-30

Douglas Ward active positions

Companies	Position	Start
LUMOS DIAGNOSTICS HOLDINGS LIMITED	Chief Executive Officer	2022-06-20

All active positions of Douglas Ward

Former positions of Douglas Ward

Companies	Position	End
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Chief Executive Officer	2020-04-20
HOLOGIC, INC.	Corporate Officer/Principal	-

See the detail of Douglas Ward's experience

Training of Douglas Ward

Ohio Wesleyan University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Douglas Ward's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
HOLOGIC, INC.	Health Technology
LUMOS DIAGNOSTICS HOLDINGS LIMITED	Health Technology

Private companies	1
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Health Technology